GlassScriptPhysician profile
Frederick W Feuerstein
NPI 1578678413
$2,591.33
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $477 · 2021: $1,359 · 2022: $75.81.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $473.99 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $332.51 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $288.25 | 2019-2021 | |
| Abbvie INC. | $255.40 | 2021-2022 | |
| Novo Nordisk INC | $195.28 | 2019-2021 | |
| Amgen INC. | $181.54 | 2019-2021 | |
| Lilly USA, LLC | $117.09 | 2021 | |
| Pfizer INC. | $98.81 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $76.39 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $69.66 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.14 | 2019-2021 | |
| Eisai INC. | $49.52 | 2019-2021 | |
| Amarin Pharma, INC. | $45.66 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $45.25 | 2021 | |
| Medicure Pharma INC. | $39.30 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $36.54 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.57 | 2019 | |
| Abbott Laboratories | $31.38 | 2021 | |
| Arbor Pharmaceuticals, INC. | $24.67 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $22.47 | 2019 | |
| Scilex Pharmaceuticals INC. | $19.45 | 2019 | |
| Allergan, INC. | $17.97 | 2019 | |
| Genentech USA, INC. | $17.95 | 2020 | |
| Bausch Health US, LLC | $16.71 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.06 | 2021 | |
| Avanir Pharmaceuticals, INC. | $11.57 | 2021 | |
| Glaxosmithkline, LLC. | $11.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Feuerstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.